Bclc Hepatocellular Carcinoma Stage
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- D≥ 4
- C≥ 3
- B≥ 2
- A≥ 1
The Bclc Hepatocellular Carcinoma Stage calculates assessing gastrointestinal disease severity, endoscopic intervention urgency, and rebleeding risk. Key inputs include tumor burden. Scores guide timing emergent endoscopy, initiating high-dose proton pump inhibitor infusions, or obtaining surgical consultation. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma.
Clinical Indication
The Bclc Hepatocellular Carcinoma Stage is indicated for bedside clinical practice to support Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with upper or lower gastrointestinal hemorrhage, acute pancreatitis, acute liver failure, or inflammatory bowel disease. Clinical application is indicated across Endoscopy suites, emergency GI triage, acute medical floors, and hepatology services.
Limitations & Contraindications
Initial hemoglobin values in hyperacute hemorrhage may falsely appear normal prior to complete extravascular-to-intravascular fluid equilibration.
Clinical Pearls & Action Plan
Aggressive intravascular volume resuscitation and blood product support must precede diagnostic or therapeutic endoscopy.
0: single <2cm/CP-A/PS0; A: single or <=3x<=3cm/CP A-B/PS0; B: multinodular/CP A-B/PS0; C: vascular invasion or spread or PS1-2; D: CP-C or PS>2.
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| tumor_burden | string | Yes | single_lt2cm: single <2cm; single_or_limited: single any size or <=3 nodules <=3cm; multinodular: beyond |
| vascular_invasion | string | Yes | Vascular invasion: yes, no |
| extrahepatic_spread | string | Yes | Extrahepatic spread: yes, no |
| child_pugh | string | Yes | Child-Pugh class: A, B, C |
| performance_status | int | Yes | ECOG performance status (0-4) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| ≥ 4 | D | Terminal stage |
| ≥ 3 | C | Advanced stage |
| ≥ 2 | B | Intermediate stage |
| ≥ 1 | A | Early stage |
| ≥ 0 | 0 | Very early stage |
Evidence-Based References (EBM)
- Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation. J Hepatol. 2022;76(3):681-693.